|
Volumn 34, Issue 1, 2001, Pages 123-127
|
Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine
|
Author keywords
Hepatitis B surface antigen: Antibodies to HBsAg; Immunity to hepatitis B; Immunization; Pre S1; Pre S2
|
Indexed keywords
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B VACCINE;
RECOMBINANT HEPATITIS B VACCINE;
ADULT;
ANTIBODY TITER;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
HEPATITIS B;
HUMAN;
IMMUNE RESPONSE;
IMMUNIZATION;
IMMUNOGENICITY;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEROCONVERSION;
TREATMENT OUTCOME;
VIRUS HEPATITIS;
ADULT;
FEMALE;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VACCINES;
HUMANS;
IMMUNIZATION;
MALE;
PROTEIN PRECURSORS;
TIME FACTORS;
VACCINES, SYNTHETIC;
|
EID: 0035133043
PISSN: 01688278
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-8278(00)00082-9 Document Type: Article |
Times cited : (68)
|
References (22)
|